Generics

DUBLIN — Endo on Monday announced the appointment of two key executive leadership team members, naming Terrance J. Coughlin its EVP and COO, and adding Tony Pera as the president of Endo’s U.S. generics company Par Pharmaceutical. The appointments are effective Nov. 1. 

 

PISCATAWAY, N.J. — Camber Pharmaceuticals on Thursday announced the launch of its generics of Avodart (dutasteride) capsules and Levaquin (levofloxacin) tablets.

 

The company’s dutasteride capsules will be available in 30- and 90-count bottles of 0.5 mg dosage strengths. The drug is indicated to treat enlarged prostate. 

 

SILVER SPRING, Md. — The Food and Drug Administration has approved Lupin’s generic of Janssen Pharmaceuticals’s Ortho-Cyclen 28 (norgestimate/ethinyl estradiol) tablets. 

 

The contraceptive had U.S. sales of $178.2 million for the 12 months ended June 2016, according to QuintilesIMS data. 

 

BRIDGEWATER, N.J. — Ajanta Pharma USA has launched its generic of Azor (amlodipine and olmesartan medoxomil) tablets, the company announced Wednesday. The drug is indicated to treat high blood pressure. 

 

Ajanta’s generic will be available in 5 mg/20 mg, 5 mg/40mg, 10 mg/20 mg and 10 mg/40 mg dosage strengths.

 

DUBLIN — Endo announced Tuesday that Par Pharmaceutical had begun shipping its generic of Seroquel XR (quetiapine fumarate extended-release) tablets. Par will have 180 days of market exclusivity for the 50-, 100-, 150-, 200- and 300-mg dosage strength tablets. 

 

The drug  had U.S. sales of $911 million for the 12 months ended September 2016, according to QuintilesIMS data. Profits from Par’s generic will be shared with its partners Hand Pharmaceuticals and Deerfield Generics. 

 

PISCATAWAY, N.J. — Camber Pharmaceuticals on Monday announced the launch of its Crestor (rosuvastatin) generic. The drug is indicated to treat high triglycerides and cholesterol.

 

Crestor had U.S. moving annual total sales of $6.43 billion for the 12 months ended May 2016, according to IMS Health data. Camber’s generic will be available in 90-count bottles of 5-, 10- and 20-mg dosage strengths, and 30-count bottles of 40-mg dosage strength. 

 

MISSISSAUGA, Ontario — Specialty pharmacy company Aralez Pharmaceuticals on Monday announced the completion of its acquisition of the U.S. rights to AstraZeneca’s extended-release beta blocker, Toprol-XL (metoprolol succinate) and its authorized generic. Aralez paid $175 million at closing.